Skip to main content

COVID-19 Topic Center

Medication Errors Expert Insights

Pharmacy Learning Network
By Damon Birkemeier, PharmD, FDA/ISMP safe medication management fellow In part I of this two-part blog, we introduced a survey conducted by the Institute for Safe Medication Practices (ISMP) that evaluated technologies, policies, and procedures in place as well as identified major safety concerns…
Pharmacy Learning Network
By Damon Birkemeier, PharmD, FDA/ISMP safe medication management fellow Millions of compounded sterile products (CSPs) are produced each year, many of which are in hospital pharmacies. The Institute of Safe Medication Practices (ISMP) launched a survey intended to gather insights into pharmacy…
Pharmacy Learning Network
Benzodiazepines (BZs) are one of the most heavily prescribed medications. Since chlordiazepoxide was first approved in 1960, statistics on their use are staggering. From 1996 to 2013 the percentage of adults who filled a BZs prescription per year increased 30%. 1 In 2008, approximately 5.2% of…
Pharmacy Learning Network
Pfizer Inc. is recalling more than 19,000 vials of fentanyl citrate injection due to a lack of sterility assurance. The August 12, 2020, US Food and Drug Administration (FDA) Enforcement Report cites “potential loose metal overseal crimp defects.”  The recall affects fentanyl citrate injection,…
Pharmacy Learning Network
By Yashar Rafi, PharmD, 2019-2020 ISMP Safe Medication Management Fellow In the first part of this blog, we looked at the new Best Practice 15 from the 2020-2021 Targeted Medication Safety Best Practices for Hospitals which deals with fentanyl patches and extended-release and long-acting opioid…
Pharmacy Learning Network
By Yashar Rafi, PharmD, 2019-2020 ISMP Safe Medication Management Fellow On February 21, 2020 ISMP released its 2020-2021 Targeted Medication Safety Best Practices for Hospitals. The purpose of this resource is to mobilize widespread adoption of consensus-based Best Practices to address recurring…
Pharmacy Learning Network
By: Neha Kumar, PharmD, 2019-2020 FDA/ISMP Safe Medication Management Fellow  This blog is a continuation of our three-part series regarding errors that have been extracted from ISMP Canada1 and ISMP analysis of oxytocin incidents. Part I covered prescribing errors and part II…
Pharmacy Learning Network
By: Neha Kumar, PharmD, 2019-2020 FDA/ISMP Safe Medication Management Fellow This blog is a continuation of our series regarding errors that have been extracted from ISMP Canada1 and ISMP analysis of oxytocin incidents. In part I we discussed prescribing errors, along with related safe…
Pharmacy Learning Network
Matthew Grissinger, RPh, director of error reporting, ISMP, discusses cross-contamination risk of COVID-19 when handling medications and provides tips to help mitigate this risk.   
Pharmacy Learning Network
By: Neha Kumar PharmD, 2019-2020 FDA/ISMP Safe Medication Management Fellow Intravenous (IV) oxytocin is indicated for the induction or stimulation of labor, control of postpartum uterine bleeding, and adjunctive treatment of abortion. However, improper administration of oxytocin can…
Back to Top